Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

PSCAN, which enables minimally invasive, wide-field, high-resolution imaging of the nucleus tractus solitarii (NTS) in living mice. This technique allows detailed investigation of NTS activity and ...

Twist Bioscience's silicon-based DNA writing platform offers competitive advantages in synthetic DNA, NGS consumables, and ...

The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...

Three children have died in the most recent outbreak of measles, to date. This article reviews the signs, symptoms, and ...

Fabrice Gritti, consultant scientist at Waters Corporation, spoke to LCGC International about the history of slalom ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Repligen targets 10% to 15% growth in its proteins franchise, supported by new resin launches, including the double-stranded RNA resin introduced in late 2024. Revenue for Q1 2025 totaled $169 million ...

Scientists develop RNA-based technology to combat plant viruses, enhancing crop immunity and reducing losses worldwide.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), ...